David Evans, Ph.D. in

David Evans, Ph.D.

Login to view DISC.
Head of Discovery at Sirnaomics
📍 Germantown, Maryland, United States

David Evans is the Head of Discovery Research and co-founder of Sirnaomics, where he leads the development of siRNA therapeutics for oncology, fibrosis, and infectious diseases. An alumnus of Imperial College London, he is a seasoned R&D leader with extensive experience in driving multiple drug candidates from discovery to clinical-stage trials.

He is described as a creative leader who is rich in ideas for new technological solutions to problems in drug screening. People who have worked with him note that he fosters an innovative and enjoyable work environment.

Interesting fact: David is a serial entrepreneur, having co-founded several therapeutic, diagnostic, and instrumentation companies throughout his career.

Read the full overview →
Experience
31 Years
Current Role
Head of Discovery
Job Level
Mid-senior
Location
Germantown, Maryland, United States
Personality Overview

How David shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics David cares about

RNAi Therapeutics
He is a pioneer in the field, leading Sirnaomics' efforts in developing novel siRNA therapeutics and has been involved in RNAi since 2003.
Oncology Drug Discovery
His work is heavily focused on developing treatments for various cancers, including Non-Melanoma Skin Cancer, TNBC, and NSCLC, using novel delivery mechanisms.
+5 more topics Login to view topics
Career

Work history

3-2023
Head of Discovery
Sirnaomics
6-2018 - 3-2023
Chief Scientific Officer
Sirnaomics
3-2013 - 6-2018
Manager In Vitro Screening groups
Frederick National Lab for Cancer Research (NCI)
1-2012 - 12-2012
VP Operations
Emerald BioStructures and BioSystems
6-2008
Scientific advisor
Consultant
In the press

Media appearances

Sirnaomics Appoints Dr. David Evans as Chief Scientific Officer to Lead Preclinical Programs for Novel Antifibrosis and Anticancer RNAi Therapeutics. Featured in PR Newswire
See now
Dr. David Mark Evans – Head: Drug Discovery & Collaboration, Sirnaomics Ltd. Featured in Bloomberg
+2 more appearances Login to view media
Education
10-1983 - 6-1987
Ph.D
Imperial College London
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to David. Free, 10 seconds.